{
  "bio": [
    "Kiran Mazumdar-Shaw, one of India's richest self-made women, founded biopharmaceutical firm Biocon, in 1978. The firm has successfully forayed into the lucrative U.S. market.",
    "The company has Asia's largest insulin factory in Malaysia's Johor region.",
    "In 2022, Biocon Biologics inked a deal to acquire the biosimilars business of Viatris for $3.3 billion.",
    "In 2022, the Central Bureau of Investigation arrested a Biocon Biologics executive and four others in an alleged bribery case. The company denied any wrongdoing.",
    "In 2023, vaccine billionaire Cyrus Poonawalla's Serum Institute of Life Sciences doubled its investment in Biocon Biologics, a Biocon subsidiary, to $300 million."
  ],
  "about": [
    "Mazumdar-Shaw wanted to be a doctor but couldn't get into medical school.",
    "In 2019, she and late husband John Shaw, donated $7.5 million to the University of Glasgow to create a research hub and a professorial chair of precision oncology.",
    "Biocon is working with U.S. firm Adagio Therapeutics to develop an antibody therapy called ADG20 to prevent and treat the coronavirus and its variants.",
    "Her philanthropic initiative, Mazumdar Shaw Medical Center, aims to create a sustainable, affordable cancer care model."
  ]
}